Previous studies showed that FOSL2 expression promotes proliferation, migration, and invasion of cancers, including osteosarcoma [26], hepatocellular carcinoma [27], and colon cancer [28, 29]. This evidence concerns the gene FOSL2 and hepatocellular carcinoma.